Status: Recruiting
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
The use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).
Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Methodist Health SystemUpdated: Jun 10, 2026Locations: 1
Eligibility criteria
≥ 18 years [+3]
Death within 48 hours post-PCI [+1]